PTGFR activation promotes the expression of PTGS-2 and growth factors via activation of the PKC signaling pathway in bovine endometrial epithelial cells

Anim Reprod Sci. 2018 Dec:199:30-39. doi: 10.1016/j.anireprosci.2018.10.003. Epub 2018 Oct 14.

Abstract

The endometrium of domestic animals has a remarkable capacity to self-repair. Prostaglandin F (PGF) is one of the major prostaglandins secreted from the endometrium. The role of PGF in endometrial repair, however, is still unknown. In the present study, it was investigated whether prostaglandin F receptor (PTGFR) activation could induce expression of prostaglandin-endoperoxide synthase 2 (PTGS-2) and growth factors associated with endometrial repair via activation of protein kinase C (PKC) signaling in endometrial epithelial cells (bEECs) of cattle. Results of the present study indicated that the treatment with the PTGFR agonist, fluprostenol, resulted in an increase in abundance of proteins for PTGS-2, vascular endothelial growth factor (VEGF), connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGF-β1), and interleukin-8 (IL-8). The increased abundances of these proteins were suppressed by the treatment with the PTGFR antagonist, AL8810.Furthermore, fluprostenol treatment also induced PKC phosphorylation. Subsequently, treatment with AL8810 inhibited the fluprostenol-induced PKC phosphorylation. Additionally, treatment with the PKC inhibitor, chelerythrine, reduced the fluprostenol-induced increase in the relative abundance of VEGF, CTGF, TGF-β1, and IL-8 mRNA in bEECs. Taken together, these results suggest that PTGFR activation may induce endometrial repair by upregulating PTGS-2 gene expression and stimulating VEGF, CTGF, TGF-β1, and IL-8 gene expression via activation of the PKC signaling pathway.

Keywords: Growth factors; PKC signaling; PTGFR activation; PTGS-2; bEECs.

MeSH terms

  • Animals
  • Cattle / metabolism*
  • Cells, Cultured
  • Connective Tissue Growth Factor / genetics
  • Connective Tissue Growth Factor / metabolism
  • Dinoprost / analogs & derivatives
  • Dinoprost / pharmacology
  • Endometrium / cytology
  • Endometrium / drug effects
  • Endometrium / metabolism*
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Female
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Interleukin-8 / genetics
  • Interleukin-8 / metabolism
  • Luteolytic Agents / pharmacology
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Prostaglandins F, Synthetic / pharmacology
  • Protein Kinase C / genetics
  • Protein Kinase C / metabolism
  • Receptors, Prostaglandin / agonists
  • Receptors, Prostaglandin / antagonists & inhibitors
  • Receptors, Prostaglandin / metabolism
  • Signal Transduction*
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • AL 8810 ethylamide
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-8
  • Luteolytic Agents
  • Prostaglandins F, Synthetic
  • Receptors, Prostaglandin
  • Transforming Growth Factor beta1
  • Vascular Endothelial Growth Factor A
  • prostaglandin F2alpha receptor
  • Connective Tissue Growth Factor
  • fluprostenol
  • Dinoprost
  • Prostaglandin-Endoperoxide Synthases
  • Protein Kinase C